Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Interpace Biosciences, Inc. (IDXG : OTC)
 
 • Company Description   
Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.

Number of Employees: 147

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.30 Daily Weekly Monthly
20 Day Moving Average: 6,621 shares
Shares Outstanding: 4.23 (millions)
Market Capitalization: $13.95 (millions)
Beta: 1.28
52 Week High: $10.51
52 Week Low: $2.76
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -21.05% -16.37%
12 Week -34.00% -27.89%
Year To Date -55.82% -46.58%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
MORRIS CORPORATE CENTER 1 BUILDING C 300 INTERPACE PARKWAY
-
PARSIPPANY,NJ 07054
USA
ph: 855-776-6419
fax: 862-207-7820
jgreen@edisongroup.com http://www.interpace.com
 
 • General Corporate Information   
Officers
Thomas W. Burnell - Chief Executive Officer;President
Robert Gorman - Chairman of the Board of Directors
Thomas Freeburg - Chief Financial Officer and Treasurer
Stephen J. Sullivan - Director
Joseph Keegan - Director

Peer Information
Interpace Biosciences, Inc. (CHCR)
Interpace Biosciences, Inc. (ESRX)
Interpace Biosciences, Inc. (MYDP)
Interpace Biosciences, Inc. (GBCS)
Interpace Biosciences, Inc. (LAXAF)
Interpace Biosciences, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 46062X303
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 4.23
Most Recent Split Date: 1.00 (0.10:1)
Beta: 1.28
Market Capitalization: $13.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.52 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 0.33
EPS Growth
vs. Year Ago Period: 49.02%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 5.53%
vs. Previous Quarter: -4.39%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -31.91
12/31/21 - -35.58
09/30/21 - -44.22
Current Ratio
03/31/22 - 0.78
12/31/21 - 0.78
09/30/21 - 0.57
Quick Ratio
03/31/22 - 0.78
12/31/21 - 0.78
09/30/21 - 0.57
Operating Margin
03/31/22 - -30.55
12/31/21 - -35.69
09/30/21 - -47.69
Net Margin
03/31/22 - -31.02
12/31/21 - -36.17
09/30/21 - -48.26
Pre-Tax Margin
03/31/22 - -32.13
12/31/21 - -37.31
09/30/21 - -49.37
Book Value
03/31/22 - -10.49
12/31/21 - -10.16
09/30/21 - -9.29
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©